戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 most common mutation is in the gene encoding complement factor H.
2 02 protein polymorphism in the gene encoding complement factor H.
3 ed, i.e., TSG-6, chemokines IL-8 and KC, and complement factor H.
4 The purified protein was identified as human complement factor H.
5  and OPN form rapid and tight complexes with complement Factor H.
6  the complement cascade C1q, C6, and C8; and complement factor H.
7 ble proteins, such as C-reactive protein and complement factor H.
8               We have recently reported that complement factor H, a negative regulator of complement-
9                 Indeed, the binding of human complement factor H, a negative regulator of the alterna
10       Genetic investigations have shown that complement factor H, a regulator of the alternative comp
11                     Ten loci in 7 AMD genes [complement factor H, age-related maculopathy susceptibil
12                                Deficiency of complement factor H and mutations in CFH associate with
13                         In mice deficient in complement factor H and transgenic for human CR1, solubl
14               The association of variants in complement factors H and B with age-related macular dege
15 g two host-derived fluid-phase regulators of complement, factor H and factor H-like protein 1 (FHL-1)
16 d with genetic complement abnormalities/anti-complement factor H antibodies, which paved the way to t
17 convalescent B1b cell-derived IgM recognizes complement factor H-binding protein (FhbA), a B. hermsii
18           Genetic risk was based on Y402H in complement factor H (CFH) and A69S in age-related maculo
19 ants were genotyped for polymorphisms in the complement factor H (CFH) and age-related maculopathy su
20            Two biologically related factors, complement factor H (CFH) and C-reactive protein (CRP),
21  the relationship between local (ie, ocular) complement factor H (CFH) and choroidal neovascularizati
22               Association of variants in the complement factor H (CFH) and complement factor B (CFB)
23 tion cluster at chromosome 1q32 contains the complement factor H (CFH) and five complement factor H-r
24 s study, we investigated the associations of complement factor H (CFH) and hemicentin-1 (HMCN1) with
25 ctivation and genetic variants in inhibitory complement factor H (CFH) are also features of both ARMD
26  In addition, to determine the regulation of complement factor H (CFH) by oxidative stress, in vitro
27                        Genetic variations in complement factor H (CFH) confer greater risk for age-re
28 f this disease, identifying mutations in the complement factor H (CFH) gene and a locus on chromosome
29                         Rare variants in the complement factor H (CFH) gene and their association wit
30 anding puzzle why non-coding variants in the complement factor H (CFH) gene are more strongly associa
31                            Variations in the complement factor H (CFH) gene are tightly associated wi
32 S, with a focus on genetic variations in the complement Factor H (CFH) gene cluster and CFH autoantib
33 us carriers of the Y402H risk variant in the complement factor H (CFH) gene developed neovascular AMD
34 ransition at amino acid position 402) in the complement factor H (CFH) gene have a pharmacogenetics e
35 ty variants and protective haplotypes in the complement factor H (CFH) gene modulate risk for AMD.
36 mparted by carrying the Y402H variant in the complement factor H (CFH) gene on chromosome 1, recent e
37 on of a rare, high-penetrance variant in the complement factor H (CFH) gene that is also causally ass
38                         Polymorphisms in the complement factor H (CFH) gene that reduce activity of C
39         A Tyr402His variant in exon 9 in the complement factor H (CFH) gene was also significantly as
40  A locus on chromosome 1q31.1 containing the complement factor H (CFH) gene was strongly associated w
41 inly been attributed to a risk allele in the complement factor H (CFH) gene.
42 ted maculopathy susceptibility 2 (ARMS2) and complement factor H (CFH) genotypes, and other factors,
43                                              Complement factor H (CFH) has recently been identified a
44 gh interaction with an SNP (rs380390) in the complement factor H (CFH) intron reported to be highly a
45                                              Complement factor H (CFH) is a central regulator of the
46                                              Complement factor H (CFH) is a component of the mammalia
47                                              Complement factor H (Cfh) is a key plasma protein in hum
48                                              Complement factor H (CfH) is a key regulator of the alte
49                                              Complement factor H (Cfh) is a key regulator of the alte
50                                              Complement factor H (CFH) is a major susceptibility gene
51                                              Complement factor H (CFH) is a negative regulator of the
52                                       Plasma complement factor H (Cfh) is a potent complement regulat
53                                              Complement factor H (CFH) is an important regulatory pro
54 Y402H and I62V substitutions in the gene for complement factor H (CFH) is strongly associated with ri
55 associated loci and 6 additional SNPs at the complement factor H (CFH) locus.
56 eptor 1 (CR1) on human erythrocytes (Es) and complement factor H (CFH) on rodent platelets perform im
57 This activation is efficiently suppressed by complement factor H (CFH) on self-surfaces but not on fo
58 smoking, and presence of risk alleles of the complement factor H (CFH) or age-related maculopathy sus
59 plicated in the disease pathology, including complement factor H (CFH) precursor and alpha-2-macroglo
60                                              Complement factor H (CFH) regulates complement activatio
61 erage of 10.1 years, individuals with 1 or 2 complement factor H (CFH) risk alleles derived maximum b
62  hyperopia, and AMD-susceptibility genotypes Complement Factor H (CFH) RS1061170 and Age Related Macu
63                                  Two loci in complement factor H (CFH) were included in a risk score
64  have associated a common variant (Y402H) of complement factor H (CFH) with a highly significant incr
65 tomegalovirus (CMV) immunoglobulin (Ig)G and complement factor H (CFH) Y402H genotype.
66                                These include complement factor H (CFH), a negative regulator of C3 ac
67 t form of HUS maps to chromosome 1q and that complement factor H (CFH), a regulatory component of the
68                 Ten genetic loci in 7 genes [complement factor H (CFH), age-related maculopathy susce
69 mplementary to the 3'-untranslated region of complement factor H (CFH), an important repressor of the
70 y complement fluid-phase regulatory protein, complement factor H (CFH), are strongly associated with
71                          Genetic variants of complement factor H (CFH), C3, C2, and FB associated wit
72 ilies were filtered for rare variants in the complement factor H (CFH), complement factor I (CFI), co
73  Genetic variation across the genes encoding complement factor H (CFH), factor B (CFB) and component
74 with the physiological complement inhibitor, complement factor H (CFH), for ligand binding.
75 sm, encoding the sequence variation Y402H in complement factor H (CFH), has been strongly associated
76           Variants of the CFH gene, encoding complement factor H (CFH), show strong association with
77     Two common variants in the gene encoding complement factor H (CFH), the Y402H substitution (rs106
78 that binds the negative complement regulator complement factor H (CFH), thereby inhibiting the altern
79 ponses by hijacking a host-immune regulator, complement factor H (CFH), to the bacterial surface.
80 ly it to a comparison of hemopexin (HPX) and complement factor H (CFH), two liver-secreted glycoprote
81                                              Complement factor H (CFH), which inhibits complement act
82 ificant peak was found on chromosome 1, near complement factor H (CFH), with P= 6.20 x 10(-4).
83 th age, sex, smoking status, presence of the complement factor H (CFH)-rs1061170 and age-related macu
84 oth common and rare, in the coding region of complement factor H (CFH).
85 omplement proteins or autoantibodies against complement factor H (CFH).
86 ted maculopathy susceptibility 2 (ARMS2) and complement factor H (CFH).
87 ANGPT1) and four retinal genes interact with Complement Factor H (CFH).
88 her [age-related macular degeneration (AMD); complement factor H (CFH)], or even three disease charac
89   Genetic risk factors such as variations in complement factors H (CFH) and B (CFB) have been implica
90                                        Human complement factor H, consisting of 20 complement control
91                                        Human complement factor H controls spontaneous activation of c
92 model of MPGN that develops spontaneously in complement factor H-deficient mice (Cfh(-/-)).
93 ns extend freely into solution when the five complement factor H domains are bound within C3b.
94                        Further, we show that complement factor H (FH) binds mCRP to dampen its proinf
95                       The ability to recruit complement factor H (FH) by S. pneumoniae has been impli
96                 PspC was found to bind human complement factor H (FH) by Western blot analysis of D39
97 plement control protein (CCP) modules within complement factor H (fH) encompass binding sites for C3b
98 iC3b, and C3dg and enhanced competition with complement factor H (FH) in surface plasmon resonance (S
99                                              Complement factor H (FH) inhibits complement activation
100                                              Complement factor H (fH) is a plasma protein that regula
101                                          The complement factor H (FH) mutation R1210C, which was desc
102                                     Numerous complement factor H (FH) mutations predispose patients t
103                The Tyr402His polymorphism of complement factor H (FH) with 20 short complement regula
104 soluble plasma-regulatory proteins including complement factor H (fH), a 155 kDa protein composed of
105 ement-mediated innate immunity by recruiting complement factor H (FH), a complement alternative pathw
106                                              Complement factor H (fH), a molecule that downregulates
107  human secretory immunoglobulin A (sIgA) and complement factor H (FH).
108 ve regulator of the AP is the plasma protein complement factor H (FH).
109 Alternative pathway activity is inhibited by complement factor H (FH).
110 MD (P = .03); between rs2669845 and Y402H in complement factor H for AMD (P = .04); and between rs266
111                         Polymorphisms in the complement factor H gene (CFH) are associated with a sig
112 typed, an intronic and common variant in the complement factor H gene (CFH) is strongly associated wi
113 actors--smoking and the Y402H variant of the complement factor H gene (CFH)--we used logistic regress
114 a contiguous 358 kb region that contains the Complement Factor H gene cluster.
115 tion studies have found variation within the complement factor H gene family links to host susceptibi
116                   Inherited variation in the complement factor H gene is a major risk factor for drus
117 kely caused by the Y402H polymorphism in the complement factor H gene is a recognized risk factor for
118  T-->C substitution in exon 9 (Y402H) of the complement factor H gene is strongly associated with sus
119  age, sex, and the Y402H polymorphism in the complement factor H gene on chromosome 1q) and mortality
120                      DNA resequencing of the complement factor H gene within this haplotype revealed
121                                              Complement factor H genotype had no effect on the respon
122                                Deficiency of complement factor H has long been associated with MPGN.
123 ain, antithrombin III, Fas ligand, factor V, complement factor H, IgK, and Fas.
124  work presented here demonstrates that human complement factor H is an adhesion ligand for human neut
125 und in locus 1q31.3, containing the gene for complement factor H (lead single nucleotide polymorphism
126 n up to 50% of cases, caused by mutations in complement factor H, membrane cofactor protein, factor I
127 etic mutation causing aHUS, including 4 with complement factor H mutations.
128 fluid-phase CRP to six immobilized proteins: complement factor H, oxidized low-density lipoprotein, c
129 serine peptidase 1) (P =2.7 x 10(-72)), CFH (complement factor H) (P =2.3 x 10(-47)), C2 (complement
130                                          The complement factor H R1210C rare variant confers the stro
131                 The typical phenotype of the complement factor H R1210C rare variant is associated wi
132 is revealed a novel heterozygous mutation in complement factor H (R83S) in addition to known risk pol
133 tients carrying a genetic abnormality in the complement factor H related 1 gene (CFHR1) that originat
134                          We demonstrate that complement factor-H related 3 (CFHR3) promotes immune ac
135                Copy number variations in the complement factor H-related (CFHR) gene cluster on chrom
136 and identified a chromosomal deletion in the complement factor H-related (CFHR) gene cluster.
137   The autoimmune renal disease deficient for complement factor H-related (CFHR) genes and autoantibod
138 tains the complement factor H (CFH) and five complement factor H-related (CFHR) genes.
139 n includes genomic rearrangements within the complement factor H-related (CFHR) locus.
140                              The role of the complement factor H-related (FHR) proteins in homeostasi
141  C3G-associated genomic mutation in the gene complement factor H-related 1 (CFHR1), which encodes FHR
142 onstrates that a duplication within the gene complement factor H-related 1 (CFHR1; encoding FHR1) lea
143 ociation studies have shown that deletion of complement factor H-related genes 1 and 3 (CFHR3,1Delta)
144 e association studies identified deletion of complement factor H-related genes 1 and 3 as protective
145                                        Human complement factor H-related protein (CFHR) 4 belongs to
146 ing the association of rs7517126 with plasma complement factor H-related protein 1 (CFHR1) level at p
147 , Factor H, Factor H-like protein-1 (FHL-1), complement Factor H-related protein 1 (CFHR1), and plasm
148  and endogenous nitric oxide production) and complement factor H-related protein 2 (CFHR2, related to
149 e cosegregated with the same mutation in the complement factor H-related protein 5 gene (CFHR5).
150                                              Complement factor H-related proteins (FHRs) are strongly
151 riants suggest decreased inhibition of C3 by complement factor H, resulting in increased activation o
152                            Interactions with complement factor H (rs1061170), age-related maculopathy
153                                  The role of complement factor H still needs to be better defined, bu
154 d, followed by the first five SCR domains of complement factor H that bind to complement C3b.
155  noncoding variant in CFH, the gene encoding complement factor H, that substantially increases the in
156  with these diseases affect the glycoprotein complement factor H, the main regulator of the alternati
157 first to a cell surface receptor and then to complement Factor H thereby blocking the lytic activity
158 are disrupted by the abundant serum protein, complement Factor H, thereby probably limiting SIBLING-m
159  characteristic of sub-RPE deposits, such as complement factor H, vitronectin, and amyloid beta, reve
160 a-2-glycoprotein and positively with afamin, complement factor H, VLDL-associated apolipoproteins, an
161 leukin-6 (IL-6), interleukin-10 (IL-10), and complement factor H was unaffected.
162 venger receptors, IgM natural antibodies and complement factor H, which bind, neutralize and/or facil
163  association of ARM with the Y402H allele of complement factor H, which has previously been reported
164 e mutant also had decreased binding of human complement Factor H, which in previous studies increased
165  Maculopathy Susceptibility 2 rs10490924 and Complement Factor H Y402H (P for trend = 4.2x10(-7)).

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top